Cargando…
Protein Binding Partners of Dysregulated miRNAs in Parkinson’s Disease Serum
Accumulating evidence suggests that microRNAs (miRNAs) are a contributing factor to neurodegenerative diseases. Although altered miRNA profiles in serum or plasma have been reported for several neurodegenerative diseases, little is known about the interaction between dysregulated miRNAs and their pr...
Autores principales: | Ruf, Wolfgang P., Freischmidt, Axel, Grozdanov, Veselin, Roth, Valerie, Brockmann, Sarah J., Mollenhauer, Brit, Martin, Dorothea, Haslinger, Bernhard, Fundel-Clemens, Katrin, Otto, Markus, von Arnim, Christine, Holzmann, Karlheinz, Ludolph, Albert C., Weishaupt, Jochen H., Danzer, Karin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065836/ https://www.ncbi.nlm.nih.gov/pubmed/33918274 http://dx.doi.org/10.3390/cells10040791 |
Ejemplares similares
-
Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
por: Grozdanov, Veselin, et al.
Publicado: (2014) -
T-cell dysregulation is associated with disease severity in Parkinson’s Disease
por: Bhatia, Divisha, et al.
Publicado: (2021) -
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
por: Bliederhaeuser, Corinna, et al.
Publicado: (2016) -
α-synuclein interacts with SOD1 and promotes its oligomerization
por: Helferich, Anika M., et al.
Publicado: (2015) -
Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
por: Freischmidt, Axel, et al.
Publicado: (2013)